These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19896372)

  • 41. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
    Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
    Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
    Zeiger M; Stark S; Kalden E; Ackermann B; Ferner J; Scheffer U; Shoja-Bazargani F; Erdel V; Schwalbe H; Göbel MW
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5576-5580. PubMed ID: 25466178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting HIV transcription: the quest for a functional cure.
    Mousseau G; Mediouni S; Valente ST
    Curr Top Microbiol Immunol; 2015; 389():121-45. PubMed ID: 25731772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
    Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
    Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
    Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
    RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
    Zhao H; Li J; Jiang L
    Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tertiary Element Interaction in HIV-1 TAR.
    Krawczyk K; Sim AY; Knapp B; Deane CM; Minary P
    J Chem Inf Model; 2016 Sep; 56(9):1746-54. PubMed ID: 27500460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA as a target for drug design, the example of Tat-TAR interaction.
    Froeyen M; Herdewijn P
    Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.
    Das I; Désiré J; Manvar D; Baussanne I; Pandey VN; Décout JL
    J Med Chem; 2012 Jul; 55(13):6021-32. PubMed ID: 22698070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of a new class of HIV-1 inhibitors.
    Farese-Di Giorgio A; Pairot S; Patino N; Condom R; Di Giorgio C; Aumelas A; Aubertin AM; Guedj R
    Nucleosides Nucleotides; 1999 Feb; 18(2):263-75. PubMed ID: 10067276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
    Zhang J; Tamilarasu N; Hwang S; Garber ME; Huq I; Jones KA; Rana TM
    J Biol Chem; 2000 Nov; 275(44):34314-9. PubMed ID: 10944537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.